GeneDx Holdings Corp. Reports Q2 Loss, Tops Revenue Estimates
| CODX Stock | USD 0.94 0.01 1.08% |
Slightly above 53% of Co Diagnostics' investor base is interested to short. The analysis of overall sentiment of trading Co Diagnostics stock suggests that many investors are impartial at this time. Co Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Co Diagnostics' earnings reports, geopolitical events, and overall market trends.
CODX |
GENEDX HOLDINGS delivered earnings and revenue surprises of 57.69 percent and 19.72, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
 |
Co Diagnostics Fundamental Analysis
We analyze Co Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Co Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Co Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Co Diagnostics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Co Diagnostics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Co Diagnostics stock to make a market-neutral strategy. Peer analysis of Co Diagnostics could also be used in its relative valuation, which is a method of valuing Co Diagnostics by comparing valuation metrics with similar companies.
Peers
Co Diagnostics Related Equities
| MOVE | Movano | 49.72 | ||||
| BMRA | Biomerica | 6.67 | ||||
| SENS | Senseonics Holdings | 3.33 | ||||
| NAOV | NanoVibronix | 2.82 | ||||
| HSCS | Heart Test | 1.40 | ||||
| CLPT | Clearpoint Neuro | 1.25 | ||||
| RSLS | ReShape Lifesciences | 1.23 | ||||
| NURO | NeuroMetrix | 1.18 | ||||
| NPCE | Neuropace | 0.49 | ||||
| INGN | Inogen | 0.31 | ||||
| CVRX | CVRx | 0.07 | ||||
| SRDX | SurModics | 0.10 | ||||
| NVNO | EnVVeno Medical | 0.62 | ||||
| IINN | Inspira Technologies | 2.90 | ||||
| BBLG | Bone Biologics | 3.08 | ||||
| VVOS | Vivos Therapeutics | 3.41 | ||||
| TIVC | Tivic Health | 3.85 | ||||
| BJDX | Bluejay Diagnostics | 3.87 | ||||
| RPID | Rapid Micro | 5.71 |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.